Quantum Genomics Société Anonyme (ALQGC.PA)

EUR 0.07

(0.0%)

Total Liabilities Summary of Quantum Genomics Société Anonyme

  • Quantum Genomics Société Anonyme's latest annual total liabilities in 2023 was 3.31 Million EUR , down -83.49% from previous year.
  • Quantum Genomics Société Anonyme's latest quarterly total liabilities in 2024 Q2 was 2.67 Million EUR , down 0.0% from previous quarter.
  • Quantum Genomics Société Anonyme reported annual total liabilities of 20.05 Million EUR in 2022, up 73.22% from previous year.
  • Quantum Genomics Société Anonyme reported annual total liabilities of 11.57 Million EUR in 2021, up 42.06% from previous year.
  • Quantum Genomics Société Anonyme reported quarterly total liabilities of 3.31 Million EUR for 2023 FY, down -83.49% from previous quarter.
  • Quantum Genomics Société Anonyme reported quarterly total liabilities of 3.31 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Quantum Genomics Société Anonyme (2023 - 2012)

Historical Annual Total Liabilities of Quantum Genomics Société Anonyme (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 3.31 Million EUR -83.49%
2022 20.05 Million EUR 73.22%
2021 11.57 Million EUR 42.06%
2020 8.14 Million EUR 51.65%
2019 5.37 Million EUR -18.75%
2018 6.61 Million EUR 31.06%
2017 5.04 Million EUR 85.7%
2016 2.71 Million EUR 7.89%
2015 2.51 Million EUR -48.42%
2014 4.88 Million EUR 47.01%
2013 3.32 Million EUR 68.19%
2012 1.97 Million EUR 0.0%

Peer Total Liabilities Comparison of Quantum Genomics Société Anonyme

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR 52.111%
ABIVAX Société Anonyme 131.05 Million EUR 97.474%
Adocia SA 31.87 Million EUR 89.614%
Aelis Farma SA 13.08 Million EUR 74.693%
Biophytis S.A. 15.84 Million EUR 79.115%
Advicenne S.A. 24.37 Million EUR 86.421%
genOway Société anonyme 14.45 Million EUR 77.108%
IntegraGen SA 5.97 Million EUR 44.645%
Medesis Pharma S.A. 6.42 Million EUR 48.49%
Neovacs S.A. 3.71 Million EUR 10.83%
NFL Biosciences SA 3.62 Million EUR 8.578%
Plant Advanced Technologies SA 6.78 Million EUR 51.195%
Sensorion SA 13.22 Million EUR 74.975%
Theranexus Société Anonyme 5.01 Million EUR 34.012%
TME Pharma N.V. 2.78 Million EUR -18.855%
Valbiotis SA 13.7 Million EUR 75.853%
TheraVet SA 1.48 Million EUR -122.904%
Valerio Therapeutics Société anonyme 20.46 Million EUR 83.828%
argenx SE 402.79 Million EUR 99.178%
BioSenic S.A. 32.26 Million EUR 89.741%
Celyad Oncology SA 9.97 Million EUR 66.826%
DBV Technologies S.A. 38.74 Million USD 91.457%
Galapagos NV 1.56 Billion EUR 99.788%
Genfit S.A. 105.92 Million EUR 96.875%
GeNeuro SA 20.13 Million EUR 83.564%
Hyloris Pharmaceuticals SA 8.61 Million EUR 61.564%
Innate Pharma S.A. 132.29 Million EUR 97.498%
Inventiva S.A. 101.59 Million EUR 96.742%
MaaT Pharma SA 22.46 Million EUR 85.265%
MedinCell S.A. 77.77 Million EUR 95.744%
Nanobiotix S.A. 95.74 Million EUR 96.543%
Onward Medical N.V. 25.69 Million EUR 87.119%
Oryzon Genomics S.A. 25.12 Million EUR 86.826%
OSE Immunotherapeutics SA 59.07 Million EUR 94.397%
Oxurion NV 19.73 Million EUR 83.228%
Pharming Group N.V. 228.28 Million EUR 98.55%
Poxel S.A. 53.9 Million EUR 93.859%
GenSight Biologics S.A. 34.72 Million EUR 90.468%
Transgene SA 26.51 Million EUR 87.517%
Financière de Tubize SA 123.65 Million EUR 97.323%
UCB SA 6.56 Billion EUR 99.95%
Valneva SE 341.14 Million EUR 99.03%
Vivoryon Therapeutics N.V. 4.54 Million EUR 27.202%